---
schema_version: "secwatch.filing_event.v1"
accession: "0001729149-26-000008"
form_type: "8-K"
ticker: "VMD"
cik: "0001729149"
company_name: "VIEMED HEALTHCARE, INC."
filed_at: "2026-03-04T23:59:59+00:00"
generated_at: "2026-05-15T21:44:24.239828+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Viemed posts record FY2025 revenue $270.3M; net income +33%; guides FY2026 rev $310-320M

## Summary
- Q4 revenue $76.2M (record, +26% YoY); FY revenue $270.3M (record, +21% YoY).
- FY2025 net income $14.9M ($0.37 diluted EPS), +33% YoY; adjusted EBITDA record $61.4M.
- FY2025 operating cash flow $51.9M; free cash flow $28.1M (more than doubled YoY).
- 2026 guidance: revenue $310-320M, adjusted EBITDA $65-69M, capex 10-11.5% of revenue.
- Board authorized share repurchase of up to 1,930,131 shares (~5% outstanding) through March 2027.

## SEC filing metadata
- accession: 0001729149-26-000008
- form_type: 8-K
- ticker: VMD
- cik: 0001729149
- company_name: VIEMED HEALTHCARE, INC.
- filed_at: 2026-03-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729149/000172914926000008/0001729149-26-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729149/000172914926000008/vmd-20260304.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001729149-26-000008
- JSON: https://secwatch.observer/filing/0001729149-26-000008.json
- Plain text: https://secwatch.observer/filing/0001729149-26-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.